Joshua Roth, Ph.D., M.H.A.

Joshua Roth Ph.D., M.H.A.
faculty member

Joshua Roth, Ph.D., M.H.A.

Associate Professor, Cancer Prevention Program
Public Health Sciences Division, Fred Hutch

Associate Professor
Hutchinson Institute for Cancer Outcomes Research [HICOR), Fred Hutch

Fax: 206.667.5597
Mail Stop: M3-B232

Dr. Joshua Roth assesses the value and financial impact of new cancer screening, diagnostic and treatment technologies. His research provides evidence that clinicians and patients can use to make choices about care and that can guide health care policymakers. Dr. Roth has studied the economic impacts of low-dose computed tomography, or CT, screening in lung cancer and of personalized screening strategies to improve the value of PSA testing for prostate cancer. Dr. Roth is also interested in assessing the risks and benefits of genomic testing in routine medical care. Sequencing DNA to identify genetic mutations that may be driving a patient’s cancer is becoming more prevalent, but there is limited evidence about how it affects patients’ decision-making and health outcomes. Dr. Roth also examines the economic value of research itself; he demonstrated that a Women’s Health Initiative study of combined hormone therapy showed an economic return of more than $37 billion and resulted in 126,000 fewer cases of breast cancer.

Other Appointments & Affiliations

Assistant Professor, Department of Pharmacy
University of Washington


B.S., Psychology, Union College, Schenectady, NY, 2004

M.H.A., Health Services Administration, University of Washington, 2008

Ph.D., Pharmaceutical Outcomes Research & Policy, University of Washington, 2012

Research Interests

Application of comparative effectiveness research and patient-centered outcomes research methods to inform translation of lung, breast, and prostate cancer diagnostics and therapeutics, including: observational study design, decision modeling, randomized controlled trial design, systematic review and meta-analysis

Find A Clinical Trial

Dr. Roth in the News

Clinical and budget impact of various CRC screenings

Science Spotlight - March 16, 2020

Understanding radiation therapy practices

Science Spotlight - November 18, 2019

A look at emerging sickle cell disease therapies

Hutch News - November 08, 2019

7 lung cancer misconceptions

Hutch News - November 15, 2018

Lung cancer: to screen or not to screen

Science Spotlight - August 20, 2018

Fred Hutch at ASCO

Hutch News - June 05, 2018

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email or call 206.667.2210